Silence Therapeutics

NASDAQ: SLN · Real-Time Price · USD
5.48
-0.15 (-2.66%)
At close: Aug 15, 2025, 3:59 PM
5.49
0.09%
After-hours: Aug 15, 2025, 04:10 PM EDT

Silence Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-63.09M -37.92M -75.78M -44.55M -41M -50.31M -50.39M -49.06M -50.47M -47.37M -43.55M -46.27M -45.56M -45.86M -47.8M -45.29M -38.1M
Depreciation & Amortization
426.27K 473.27K 475K 485K 484K 498K 518K 507K 503K 482K 407K 403K 412K 427K 547K 533K 517K
Stock-Based Compensation
13.34M 13.05M 11.13M 11.89M 11.61M 13.05M 13.27M 11.81M 11.87M 10.25M 10.37M 10.56M 10.22M 8.63M 9.83M 7.25M 5.21M
Other Working Capital
-21.39M -25.74M -2.88M -9.93M -9.84M -11.98M -15.06M -7.67M -8.66M -7.68M 3.4M 4.74M 36.79M 38.84M 37.56M 36.87M 1.14M
Other Non-Cash Items
-9.04M -9.83M 16.81M -3.99M -609K 7.64M 10.99M 8.48M 7.14M -559K -5.61M -1.29M -723K 42K -3.7M -85K 22.34M
Deferred Income Tax
n/a n/a 940K 1.12M 1.43M 1.43M 491K 312K n/a n/a 531K 4.65M 5.62M 4.72M 7.16M 3.05M 2.07M
Change in Working Capital
-15.89M -31.57M -6.38M -2.96M -20.07M -11.66M -15.77M -17.47M -7.78M -8.26M 3.6M 2.17M 34.55M 38.84M 37.56M 36.87M -15.32M
Operating Cash Flow
-61.64M -56.83M -43.83M -29.05M -39.19M -39.35M -40.89M -45.42M -38.74M -45.46M -34.25M -29.78M 4.52M 6.81M 3.6M 2.33M -23.29M
Capital Expenditures
-197.26K -193.26K -138.49K -88K -18K -51K -353K -380K -420K -440K -687K -971K -1.37M -1.33M -881K -570K -328K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-159.34M -128.72M -107.46M -39.44M -60.1M -20.67M -20.67M -20.66M n/a n/a 10M 10M 10M 10M n/a n/a n/a
Sales Maturities Of Investments
110.85M 110.85M 19.41M 20.1M 36.18M 36.18M 36.18M 16.08M -2K n/a n/a n/a 2K n/a n/a n/a n/a
Other Investing Acitivies
44.13M -20.59M -18.22M -37.49M -58.89M -19.7M -36.19M -36.73M -15.94M -16.15M -5.04M -41K -42K 10K 25.07M 30.37M 20.38M
Investing Cash Flow
-4.55M 803.61K -66.94M -17.47M -22.73M 16.43M -366K -21.04M -16.36M -16.54M 4.32M 9.04M 8.64M 8.68M 24.19M 29.8M 20.05M
Debt Repayment
n/a n/a -92K -92K -126K -174K -209K -175K -191K -190K -113K 308K -144K -211K -340K -746K -244K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
8.37M 1.81M -7.58M -6.64M -3.33M 3.22M 3.22M 46.3M 43.08M 43.08M 72.98M 29.9M 30.34M 30.34M 464K 192K 7.52M
Financial Cash Flow
8.36M 113.91M 132.13M 128.36M 130.7M 25.16M 15.28M 46.31M 43.12M 43.05M 72.9M 30.27M 30.21M 60.61M 30.61M 29.91M 37.74M
Net Cash Flow
-69.35M 46.35M 3.14M 79.76M 66.33M -785K -31.2M -21.84M -12.56M -18.72M 18.55M -19.67M 13.57M 46.09M 57.55M 60.92M 33.81M
Free Cash Flow
-61.82M -57M -43.95M -29.14M -39.21M -39.4M -41.24M -45.8M -39.16M -45.9M -34.94M -30.75M 3.15M 5.47M 2.72M 1.76M -23.61M